TABLE 5.

Correlations (R) Between Btx Unit Doses Injected at the last treatment into Masseter and Temporalis Muscles and the phantom‐corrected GSV of Each Condylar and Mandibular ROI

ROI	Temporalis			Masseter
	R	P‐value	n	r	P‐value	n
Condyle
Anterior pole L	.22	.21	35	−.07	.67	35
Anterior pole R	.06	.74	35	−.02	.91	35
Posterior pole L	.20	.26	34	−.22	.21	34
Posterior pole R	.33	.06	35	−.42	.01	35
Superior pole L	.18	.31	35	−.01	.96	35
Superior pole R	.30	.08	35	−.41	.01	35
Trabecular L	.14	.42	35	.01	.93	35
Trabecular R	.18	.31	35	−.13	.45	35
Mandible
Inf border L	.18	.33	32	.08	.67	32
Inf border R	.14	.43	33	−.11	.55	33
Alveolar Buccal L	.11	.54	34	−.18	.31	34
Alveolar Buccal R	−.03	.87	34	−.06	.74	34
Alveolar Lingual L	.02	.93	34	.13	.47	34
Alveolar Lingual R	.06	.74	34	−.01	.97	34
Trabecular L	−.44	.01	34	−.18	.31	34
Trabecular R	−.31	.08	34	−.20	.27	34

Bold indicates primary measures. P‐levels are not corrected for multiple comparisons; the critical level for Bonferroni corrected significance is P < .003 for secondary ROIs.